| Schedule of potential dilutive securities that would have been anti-dilutive due to net loss |
|
|
|
Year Ended December 31,
|
|
|
|
|
2015
|
|
2014
|
|
2013
|
|
|
Redeemable convertible preferred stock:
|
|
|
|
|
|
|
|
|
|
|
|
Series A
|
|
|
—
|
|
|
—
|
|
|
10,033,976
|
|
|
Series B
|
|
|
—
|
|
|
—
|
|
|
5,057,901
|
|
|
Series C
|
|
|
—
|
|
|
—
|
|
|
4,429,601
|
|
|
Series D
|
|
|
—
|
|
|
—
|
|
|
3,979,730
|
|
|
Warrants to purchase Series D redeemable convertible preferred stock
|
|
|
—
|
|
|
—
|
|
|
83,818
|
|
|
Stock options
|
|
|
5,298,510
|
|
|
5,850,211
|
|
|
5,883,885
|
|
|
Restricted stock units
|
|
|
1,220,008
|
|
|
992,665
|
|
|
—
|
|
|
| Schedule of calculation of basic and diluted net loss per share attributable to common stockholders |
|
|
|
Year Ended December 31,
|
|
|
|
|
2015
|
|
2014
|
|
2013
|
|
|
Numerator (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to holders of common stock
|
|
$
|
(26,733
|
)
|
$
|
(29,088
|
)
|
$
|
(28,300
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares of common stock outstanding, basic and diluted
|
|
|
42,420,356
|
|
|
32,075,107
|
|
|
7,432,055
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share attributable to holders of common stock, basic and diluted
|
|
$
|
(0.63
|
)
|
$
|
(0.91
|
)
|
$
|
(3.81
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|